Daniel Birnbaum

Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival.

F. Bertucci, W. Woodward, W. Symmans, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[DNA microarrays and prediction of clinical outcome in ovarian carcinoma patients].

P. Finetti, N. Cervera, R. Sabatier, 2010, Bulletin du cancer.

Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer

F. Bertucci, P. Finetti, P. Tomasini, 2023, Journal of Translational Medicine.

Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis

F. Bertucci, P. Finetti, O. Trédan, 2012, Oncogene.

Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles

P. Finetti, C. Theillet, B. Orsetti, 2008 .

Adolescents and young adults with classical Hodgkin lymphoma in North Tunisia: Insights from an adult single-institutional study.

F. Bertucci, P. Finetti, D. Birnbaum, 2020, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer.

D. Birnbaum, I. Bièche, R. Lidereau, 2000, Cancer research.

Gene expression profiling of primary breast carcinomas using arrays of candidate genes.

F. Bertucci, B. Loriod, S. Granjeaud, 2000, Human molecular genetics.

PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy

F. Bertucci, D. Birnbaum, P. Finetti, 2015, Oncotarget.

Gene expression profiling of cancer by use of DNA arrays: how far from the clinic?

F. Bertucci, C. Nguyen, R. Houlgatte, 2001, The Lancet. Oncology.